Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227617
Status:
TERMINATED
Last Update Posted:
2023-05-22
First Post:
2005-09-26
Brief Title:
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neuroendocrine Tumor |
| Gastrointestinal Carcinoid Tumor |
| Islet Cell Tumor |
| Lung Cancer |
| Neoplastic Syndrome |
Keywords:
| Name | View |
|---|---|
| metastatic gastrointestinal carcinoid tumor | View |
| recurrent gastrointestinal carcinoid tumor | View |
| regional gastrointestinal carcinoid tumor | View |
| pulmonary carcinoid tumor | View |
| gastrinoma | View |
| insulinoma | View |
| WDHA syndrome | View |
| glucagonoma | View |
| pancreatic polypeptide tumor | View |
| somatostatinoma | View |
| recurrent islet cell carcinoma | View |